Revenio Group Oyj

Equities

REG1V

FI0009010912

Advanced Medical Equipment & Technology

Real-time Estimate Tradegate Other stock markets 09:14:05 2024-05-17 am EDT			5-day change	1st Jan Change
29.11 ^EUR	-0.03%		+6.36%	+7.07%

Apr. 25	Transcript : Revenio Group Oyj, Q1 2024 Earnings Call, Apr 25, 2024
Apr. 24	Revenio Group Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Revenio Group Corporation Elects Bill Östman as Vice Chairman

April 28, 2022 at 02:15 am EDT

The Board of Directors of Revenio Group Corporation has elected Vice Chairman among its members. Board member Bill Östman has been elected Vice Chairman. The Vice Chairman performs the duties of the Chairman of the Board when the Chairman of the Board is temporarily prevented from attending.

Latest news about Revenio Group Oyj

Transcript : Revenio Group Oyj, Q1 2024 Earnings Call, Apr 25, 2024	Apr. 25
Revenio Group Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 23	CI
Revenio Group Corporation Announces Composition of Nomination and Remuneration Committee	Apr. 04	CI
Revenio Group Corporation Approves Dividend, Payable on April 15, 2024	Apr. 04	CI
Revenio Group Oyj Proposes Dividend for the Year Ended December 31, 2023, Payable on April 15, 2024	Mar. 12	CI
Transcript : Revenio Group Oyj, 2023 Earnings Call, Feb 15, 2024	Feb. 15
Revenio Group Oyj to Propose Dividend	Feb. 15	CI
Revenio Group Oyj Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 15	CI
Revenio Group Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 15	CI
Revenio Unit, iCare Enter Partnership Deal for AI Retinal Screening Service	Jan. 26	MT
Revenio Group Seeks M&A Opportunities	Nov. 30	CI
Transcript : Revenio Group Oyj - Analyst/Investor Day	Nov. 30
Transcript : Revenio Group Oyj, Q3 2023 Earnings Call, Oct 26, 2023	23-10-26
Revenio Group Oyj Provides Earnings Guidance for the Year 2023	23-10-26	CI
Revenio Group Oyj Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-26	CI
Transcript : Revenio Group Oyj, H1 2023 Earnings Call, Aug 10, 2023	23-08-10
Revenio Group Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Revenio Group Corporation Expands the Ai-Aided iCare Illume Screening Solution's Applications	23-06-07	CI
Revenio, OphtAI Enter Distribution Partnership for Retinal Image Analysis	23-05-08	MT
Transcript : Revenio Group Oyj, Q1 2023 Earnings Call, Apr 27, 2023	23-04-27
Revenio Group Oyj Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Revenio Group Oyj Approves Dividend for the Year Ended December 31, 2022, Payable on April 3, 2023	23-03-23	CI
Revenio Group Oyj Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-09	CI
Transcript : Revenio Group Oyj, 2022 Earnings Call, Feb 09, 2023	23-02-09
Revenio Group Oyj Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-09	CI

Chart Revenio Group Oyj

Duration

Period

More charts

Company Profile

Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Companyâs activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. It distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-07 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Revenio Group Oyj

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

29.12 EUR

Average target price

29.32 EUR

Spread / Average Target

+0.70%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
REVENIO GROUP OYJ	+7.07%	842M
QUIDELORTHO CORPORATION	-40.31%	2.95B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+18.54%	1.88B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-2.22%	1.63B
BIOTAGE AB	+34.26%	1.34B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-16.73%	959M
CONTEC MEDICAL SYSTEMS CO.,LTD	-22.64%	888M
VAREX IMAGING CORPORATION	-25.66%	623M
CELLAVISION AB	+11.32%	513M
PHC CO.,LTD.	-.--%	489M

Medical Diagnostic & Testing Equipment